Search results
What New Gene Therapy Means For Sickle Cell Patients
Forbes· 3 days agoThe genetic disease affects millions worldwide and at least 100,000 Americans, according to the CDC. Patients with sickle cell inherit a mutation in the ...
Low-income Floridians with sickle cell disease will have access to new gene therapies
Florida Phoenix via Yahoo News· 2 days agoNow, Floridians with sickle cell disease are closer to a functional cure after health care officials...
Novel gene-editing therapy continues to show positive results in sickle cell patients
Medical Xpress· 3 days agoThis innovative treatment modifies a patient's own blood-forming stem cells to correct the mutation...
Study discovers 'trigger gene' in IBD as researchers look for drugs to prevent the bowel disease
Fox News· 1 day agoThe disease can cause debilitating symptoms such as diarrhea, abdominal pain and cramping, blood in...
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Medical Xpress· 5 days agoA large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers...
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Motley Fool via Yahoo Finance· 3 days agoIt also is in the process of launching Casgevy, the first CRISPRgene-editing therapy ever. Casgevy...
Woman Thought Baby's Facial Feature Was Trait from Dad, Then Realizes It's Symptom of Childhood...
People via Yahoo News· 5 days agoFollowing a series of tests and a "week of nerves," Lydia...New Orleans-based genetics specialist,...
Health Minister JP Nadda urged to bring 'thalassemia' into national spotlight
Investing.com· 4 days agoHealth Minister JP Nadda urged to bring 'thalassemia' into national spotlight
Sernova Provides Update on Public Offering
NewMediaWire via Yahoo Finance· 5 days agoLONDON, Ontario and BOSTON, Massachusetts - (NewMediaWire) - June 12, 2024 - Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage...
FDA Expands Repotrectinib Label
Medscape· 5 days agoThe new accelerated approval for the TKI was based on the overall response rate in 48 patients.